PID13- COST-EFFECTIVENESS OF GANCICLOVIR IN PREVENTION OF CYTOMEGALOVIRUS DISEASE AFTER LIVER TRANSPLANTATION- A BAYESIAN APPROACH
Sep 1, 2000, 00:00
10.1016/S1098-3015(11)70695-7
https://www.valueinhealthjournal.com/article/S1098-3015(11)70695-7/fulltext
Title :
PID13- COST-EFFECTIVENESS OF GANCICLOVIR IN PREVENTION OF CYTOMEGALOVIRUS DISEASE AFTER LIVER TRANSPLANTATION- A BAYESIAN APPROACH
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70695-7&doi=10.1016/S1098-3015(11)70695-7
First page :
Section Title :
Open access? :
No
Section Order :
78